Answer
It is unknown whether darbepoetin alfa (Aranesp) passes into human milk, and risk to the breastfed child cannot be excluded; whether to discontinue breastfeeding or discontinue/abstain from Aranesp must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Aranesp solution for injection in pre-filled syringe / Aranesp solution for injection in pre-filled syringe with needle guardAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked